Valgenesis develops electronic laboratory notebook (ELN) and life sciences data integrity software for pharmaceutical, biotech, and contract research organizations. Founded in 2003 by Shlomo Linsky and headquartered in Princeton, New Jersey, the company specializes in FDA 21 CFR Part 11 compliance solutions that help organizations manage experimental data, ensure traceability, and meet strict regulatory requirements. With approximately 250 employees, Valgenesis serves a global customer base across the life sciences industry seeking to streamline laboratory operations and maintain data integrity standards required by regulatory agencies.
48 open now, 48 first appeared in the last 30d.